These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 4384740)

  • 1. Psychiatric aspects of Wilson's disease (hepatolenticular degeneration): results of psychometric tests during long-term therapy.
    Goldstein NP; Ewert JC; Randall RV; Gross JB
    Am J Psychiatry; 1968 May; 124(11):1555-61. PubMed ID: 4384740
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of penicillamine on the mental disorders associated with wilson's disease (author's transl)].
    Hach B; Hartung ML
    Nervenarzt; 1979 Feb; 50(2):115-20. PubMed ID: 424037
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mental disorders in Wilson's disease and the effect on them of penicillamine therapy].
    Růzicková R; Hauftová D
    Cesk Psychiatr; 1967 Aug; 63(4):236-42. PubMed ID: 6062332
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of penicillamine therapy and low-copper diet on dysarthria in Wilson's disease (hepatolenticular degeneration).
    Berry WR; Aronson AE; Darley FL; Goldstein NP
    Mayo Clin Proc; 1974 Jun; 49(6):405-8. PubMed ID: 4835812
    [No Abstract]   [Full Text] [Related]  

  • 5. Psychologic investigation of Wilson's disease.
    Davis LJ; Goldstein NP
    Mayo Clin Proc; 1974 Jun; 49(6):409-11. PubMed ID: 4835813
    [No Abstract]   [Full Text] [Related]  

  • 6. [The organic psycho-syndrome in Wilson's disease (longterm follow-up with psychologic testing in 4 patients during d-penicillamin-therapy) (author's transl)].
    Hayek HW; Knoll E; Widhalm S
    Monatsschr Kinderheilkd (1902); 1973 Nov; 121(11):679-83. PubMed ID: 4358747
    [No Abstract]   [Full Text] [Related]  

  • 7. Wilson's disease. Psychiatric manifestations may be the clinical presentation.
    Jackson GH; Meyer A; Lippmann S
    Postgrad Med; 1994 Jun; 95(8):135-8. PubMed ID: 8202418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic considerations on Wilson's disease].
    Tavolato B; De Zanche L
    G Psichiatr Neuropatol; 1966; 94(4):1085-93. PubMed ID: 5994293
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet.
    Goldstein NP; Tauxe WN; McCall JT; Gross JB; Randall RV
    Trans Am Neurol Assoc; 1969; 94():34-7. PubMed ID: 5374484
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical spectrum of Wilson's disease (hepatolenticular degeneration).
    Dobyns WB; Goldstein NP; Gordon H
    Mayo Clin Proc; 1979 Jan; 54(1):35-42. PubMed ID: 759736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction. Symposium on copper metabolism and Wilson's disease.
    Goldstein NP; Owen CA
    Mayo Clin Proc; 1974 Jun; 49(6):363-7. PubMed ID: 4599351
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychopathology in patients with Wilson's disease.
    Medalia A; Scheinberg IH
    Am J Psychiatry; 1989 May; 146(5):662-4. PubMed ID: 2712173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation abnormalities in Wilson's disease.
    Fischer M; Hayek H; Schnack H; Schenck W; Bauer B; Künzer W
    Ger Med Mon; 1969 May; 14(5):223-8. PubMed ID: 5807505
    [No Abstract]   [Full Text] [Related]  

  • 14. [Long-term follow-up study of seventeen cases with Wilson's disease].
    Tanaka K; Itoyama Y; Tobimatsu S; Goto I; Kuroiwa Y
    Rinsho Shinkeigaku; 1985 Nov; 25(11):1261-4. PubMed ID: 3835045
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of Wilson's disease--a long term follow-up.
    Arima M; Komiya K
    Paediatr Univ Tokyo; 1970 Dec; 18():22-4. PubMed ID: 5514643
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of Wilson's disease in asymptomatic patients.
    Arima M; Komiya K; Fujisawa A; Matsuoka K
    Proc Aust Assoc Neurol; 1968; 5(1):197-201. PubMed ID: 5709960
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnosis of treatable Wilson's disease.
    Cartwright GE
    N Engl J Med; 1978 Jun; 298(24):1347-50. PubMed ID: 349384
    [No Abstract]   [Full Text] [Related]  

  • 18. [Contribution to the clarification of the pathogenesis of osteopathies in Wilson's disease. (Hepatolenticular degeneration)].
    Vokrouhlická-RösslerovI ; Vodicková L; Neruda O
    Vnitr Lek; 1967 Oct; 13(10):1018-22. PubMed ID: 5630545
    [No Abstract]   [Full Text] [Related]  

  • 19. Ocular manifestations of Wilson's disease.
    Goel S; Sahay P; Maharana PK; Titiyal JS
    BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30846461
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experiences with long-term therapy of Wilson's disease].
    Schindler H
    Wien Z Inn Med; 1967; 48(12):465-9. PubMed ID: 5620587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.